Literature DB >> 27604604

The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease.

Cristiano A Köhler, Michael Maes, Anastasiya Slyepchenko, Michael Berk, Marco Solmi, Krista L Lanctôt, André F Carvalho1.   

Abstract

Alzheimer's disease (AD), the most common form of dementia, is a progressive disorder manifested by gradual memory loss and subsequent impairment in mental and behavioral functions. Though the primary risk factor for AD is advancing age, other factors such as diabetes mellitus, hyperlipidemia, obesity, vascular factors and depression play a role in its pathogenesis. The human gastrointestinal tract has a diverse commensal microbial population, which has bidirectional interactions with the human host that are symbiotic in health, and in addition to nutrition, digestion, plays major roles in inflammation and immunity. The most prevalent hypothesis for AD is the amyloid hypothesis, which states that changes in the proteolytic processing of the amyloid precursor protein leads to the accumulation of the amyloid beta (Aβ) peptide. Aβ then triggers an immune response that drives neuroinflammation and neurodegeneration in AD. The specific role of gut microbiota in modulating neuro-immune functions well beyond the gastrointestinal tract may constitute an important influence on the process of neurodegeneration. We first review the main mechanisms involved in AD physiopathology. Then, we review the alterations in gut microbiota and gut-brain axis that might be relevant to mediate or otherwise affect AD pathogenesis, especially those associated with aging. We finally summarize possible mechanisms that could mediate the involvement of gut-brain axis in AD physiopathology, and propose an integrative model.

Entities:  

Mesh:

Year:  2016        PMID: 27604604     DOI: 10.2174/1381612822666160907093807

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  73 in total

Review 1.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

Review 2.  Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Authors:  Md Sahab Uddin; Dewan Md Sumsuzzman; Philippe Jeandet; Tapan Behl; Abdur Rauf; Md Shah Amran; Ghulam Md Ashraf
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

3.  Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Authors:  Mona Sohrabi; Heidi L Pecoraro; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 4.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

Review 5.  Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.

Authors:  Li Lin; Li Juan Zheng; Long Jiang Zhang
Journal:  Mol Neurobiol       Date:  2018-03-09       Impact factor: 5.590

Review 6.  Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.

Authors:  Ankita Banerjee; Lilesh Kumar Pradhan; Santosh Chauhan; Pradyumna Kumar Sahoo; Kautilya Kumar Jena; Nishant Ranjan Chauhan; Saroj Kumar Das
Journal:  Arch Microbiol       Date:  2021-03-24       Impact factor: 2.552

Review 7.  Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.

Authors:  Susan Westfall; Nikita Lomis; Imen Kahouli; Si Yuan Dia; Surya Pratap Singh; Satya Prakash
Journal:  Cell Mol Life Sci       Date:  2017-06-22       Impact factor: 9.261

Review 8.  Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases.

Authors:  Yanfeng Bao; Chen Dong; Juan Ji; Zhifeng Gu
Journal:  Clin Rheumatol       Date:  2020-06-09       Impact factor: 2.980

Review 9.  Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease.

Authors:  Anna Atlante; Giuseppina Amadoro; Antonella Bobba; Valentina Latina
Journal:  Cells       Date:  2020-10-23       Impact factor: 6.600

10.  Gut microbes in neurocognitive and mental health disorders.

Authors:  Tyler Halverson; Kannayiram Alagiakrishnan
Journal:  Ann Med       Date:  2020-08-31       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.